Thermo Fisher Scientific ... (TMO)
NYSE: TMO
· Real-Time Price · USD
486.86
1.82 (0.38%)
At close: Aug 15, 2025, 12:05 PM
Thermo Fisher Scientific Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 28, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Dec 31, 2021 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 |
Net Income | 1.61B | 1.51B | 1.82B | 1.64B | 1.55B | 1.33B | 1.63B | 1.72B | 1.36B | 1.29B | 1.57B | 1.5B | 1.67B | 2.22B | 1.66B | 1.9B | 1.83B | 2.34B |
Depreciation & Amortization | 685M | 706M | 740M | 740M | 790M | 836M | 839M | 853M | 855M | 859M | 848M | 838M | 836M | 859M | 683M | 628M | 660M | 621M |
Stock-Based Compensation | n/a | n/a | n/a | 68M | 84M | 70M | 61M | 67M | 74M | 76M | 75M | 77M | 77M | 78M | 77M | 51M | 51M | 51M |
Other Working Capital | -726M | -1.43B | 742M | 30M | -216M | -787M | 1.42B | -9M | -718M | -1.53B | 1.65B | -367M | -849M | -875M | 442M | 237M | -126M | -1.32B |
Other Non-Cash Items | 147M | 206M | 132M | 89M | 108M | 58M | 139M | 91M | 149M | 181M | 81M | 152M | 58M | 259M | 566M | -20M | 145M | 266M |
Deferred Income Tax | -322M | -279M | n/a | -400M | -354M | -253M | -669M | -303M | -182M | -146M | -133M | -261M | -262M | -339M | 49M | -148M | -331M | 24M |
Change in Working Capital | -726M | -1.43B | 594M | 30M | -216M | -787M | 1.72B | -9M | -718M | -1.53B | 1.04B | -367M | -849M | -875M | -348M | 237M | -126M | -1.32B |
Operating Cash Flow | 1.4B | 723M | 3.29B | 2.17B | 1.96B | 1.25B | 3.72B | 2.41B | 1.54B | 729M | 3.49B | 1.94B | 1.53B | 2.2B | 2.69B | 2.65B | 2.23B | 1.98B |
Capital Expenditures | -294M | -362M | -480M | -272M | -301M | -347M | -405M | -332M | -284M | -458M | -550M | -547M | -506M | -640M | -831M | -524M | -540M | -628M |
Cash Acquisitions | n/a | n/a | n/a | -3.11B | 16M | 4M | 11M | -909M | -47M | -2.7B | 6M | 1M | 12M | -40M | -17.88B | -94M | -82M | -1.34B |
Purchase of Investments | -47M | -264M | n/a | -287M | -20M | -1.76B | n/a | n/a | n/a | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | 92M | 47M | 64M | n/a | n/a | n/a | 2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 53M | 99M | 500M | 1M | 5M | 7M | 18M | 60M | -112M | 20M | 19M | 1M | 75M | 10M | 15M | 2M | -4M | -27M |
Investing Cash Flow | -288M | -527M | 20M | -3.58B | -253M | -2.03B | -376M | -1.18B | -443M | -3.14B | -525M | -545M | -419M | -670M | -18.69B | -616M | -626M | -2B |
Debt Repayment | -787M | 2B | -2.5B | -1.11B | -1M | 1.21B | -1.31B | 1.97B | -1.32B | 504M | 3.49B | -1M | -1.82B | -1.01B | 8.6B | 3.12B | -1M | -2.8B |
Common Stock Repurchased | n/a | -2B | -1B | n/a | n/a | -3B | n/a | n/a | n/a | -3B | -1B | -6M | n/a | -2B | -101M | n/a | n/a | -2B |
Dividend Paid | -162M | -149M | -149M | -150M | -149M | -135M | -136M | -135M | -135M | -117M | -117M | -118M | -117M | -103M | -103M | -102M | -103M | -87M |
Other Financial Acitivies | -42M | 45M | -17M | 67M | 36M | 109M | 14M | 18M | 4M | 20M | 20M | -32M | -12M | -34M | -81M | -9M | -24M | 40M |
Financial Cash Flow | -991M | -102M | -3.67B | -1.19B | -114M | -1.82B | -1.43B | 1.85B | -1.46B | -2.59B | 2.39B | -151M | -1.91B | -3.15B | 8.47B | 3.04B | -76M | -4.85B |
Net Cash Flow | 431M | 131M | -630M | -2.43B | 1.58B | -2.58B | 1.93B | 3.02B | -347M | -5.04B | 5.6B | 1.03B | -874M | -1.71B | -7.56B | 5.01B | 1.43B | -4.73B |
Free Cash Flow | 1.1B | 361M | 2.81B | 1.89B | 1.66B | 904M | 3.32B | 2.08B | 1.26B | 271M | 2.94B | 1.39B | 1.02B | 1.56B | 1.86B | 2.13B | 1.69B | 1.35B |